Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
T Stamp A | IDAI | Sep 17, 2024 | 0.24 | -2.14 |
T-Mobile US | TMUS | Sep 17, 2024 | 202.70 | -1.53 |
T. Rowe Price Blue Chip Growth ETF | TCHP | Sep 17, 2024 | 38.73 | +0.26 |
T. Rowe Price Dividend Growth ETF | TDVG | Sep 17, 2024 | 40.54 | -0.22 |
T. Rowe Price Equity Income ETF | TEQI | Sep 17, 2024 | 41.32 | -0.02 |
T. Rowe Price Group | TROW | Sep 17, 2024 | 107.92 | +1.94 |
T. Rowe Price Growth Stock ETF | TGRW | Sep 17, 2024 | 36.78 | +0.02 |
T2 Biosystems | TTOO | Sep 17, 2024 | 2.25 | -2.60 |
Taboola.com | TBLA | Sep 17, 2024 | 3.23 | -0.31 |
Tactile Systems Technology | TCMD | Sep 17, 2024 | 14.10 | +0.79 |
Taitron Components A | TAIT | Sep 17, 2024 | 2.85 | +1.42 |
Taiwan Fund | TWN | Sep 17, 2024 | 42.53 | -0.47 |
Taiwan Index MSCI Ishares | EWT | Sep 17, 2024 | 52.31 | -0.49 |
Taiwan Semiconductor Manufacturing ADR | TSM | Sep 17, 2024 | 167.35 | -1.02 |
Take-Two Interactive Software | TTWO | Sep 17, 2024 | 152.71 | +0.17 |
Takeda Pharmaceutical ADR | TAK | Sep 17, 2024 | 14.85 | +0.34 |
TAL Education Group ADR | TAL | Sep 17, 2024 | 7.66 | +3.23 |
Talen Energy | TLN | Sep 17, 2024 | 165.87 | 0.00 |
Talis Biomedical | TLIS | Sep 17, 2024 | 4.38 | 0.00 |
Talkspace | TALK | Sep 17, 2024 | 2.17 | +13.61 |
Talos Energy | TALO | Sep 17, 2024 | 11.53 | +2.95 |
Talphera | TLPH | Sep 17, 2024 | 0.87 | -1.14 |
Tamboran Resources | TBN | Sep 17, 2024 | 19.50 | 0.00 |
Tandem Diabetes Care | TNDM | Sep 17, 2024 | 43.06 | +0.84 |
Tanger | SKT | Sep 17, 2024 | 31.41 | -1.10 |
Tango Therapeutics | TNGX | Sep 17, 2024 | 8.62 | -10.30 |
Tantech | TANH | Sep 17, 2024 | 0.16 | +1.42 |
Taoping | TAOP | Sep 17, 2024 | 0.57 | -2.11 |
Tapestry | TPR | Sep 17, 2024 | 43.28 | +0.05 |
Targa Resources | TRGP | Sep 17, 2024 | 152.02 | +0.95 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.